Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prifinium bromide - a new antispasmodic.

W Silber

    South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
    |December 8, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Prifinium bromide is a new antispasmodic drug that effectively treats esophageal spasms and incoordination. Clinical evaluations confirm its therapeutic benefits for these specific gastrointestinal motility disorders.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Surgery of the peripheral nerves.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2010
    Same author

    Complete luxation of the innominate bone.

    Proceedings. Transvaal Mine Medical Officers' Association·2010
    Same author

    No clastogenic activity of a senna extract in the mouse micronucleus assay.

    Mutation research·1999
    Same author

    Vitamin A and cancer.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·1986
    Same author

    Bread-barium swallow.

    Digestive diseases and sciences·1985
    Same author

    Carcinoma of the oesophagus: aspects of epidemiology and aetiology.

    The Proceedings of the Nutrition Society·1985

    Area of Science:

    • Gastroenterology
    • Pharmacology

    Background:

    • Esophageal motility disorders, including spasticity and incoordination, present significant therapeutic challenges.
    • Existing treatments may have limitations in efficacy or side effect profiles.

    Purpose of the Study:

    • To evaluate the clinical efficacy of a novel antispasmodic agent, prifinium bromide.
    • To determine the therapeutic effectiveness of prifinium bromide in managing esophageal spastic and inco-ordinated lesions.

    Main Methods:

    • Clinical evaluation of prifinium bromide.
    • Assessment of treatment outcomes in patients with esophageal motility disorders.

    Main Results:

    • Prifinium bromide demonstrated high effectiveness in the therapy of esophageal spastic lesions.

    Related Experiment Videos

  • The drug was also found to be highly effective for inco-ordinated lesions of the esophagus.

    • Conclusions:

    • Prifinium bromide is a promising therapeutic option for esophageal spasticity.
    • The evaluated antispasmodic agent offers significant benefits for inco-ordinated esophageal motility disorders.